vs

Side-by-side financial comparison of Katapult Holdings, Inc. (KPLT) and TREACE MEDICAL CONCEPTS, INC. (TMCI). Click either name above to swap in a different company.

Katapult Holdings, Inc. is the larger business by last-quarter revenue ($73.9M vs $62.5M, roughly 1.2× TREACE MEDICAL CONCEPTS, INC.). Katapult Holdings, Inc. runs the higher net margin — 26.8% vs -15.0%, a 41.9% gap on every dollar of revenue. On growth, Katapult Holdings, Inc. posted the faster year-over-year revenue change (17.3% vs -9.0%). TREACE MEDICAL CONCEPTS, INC. produced more free cash flow last quarter ($-10.4M vs $-12.0M). Over the past eight quarters, TREACE MEDICAL CONCEPTS, INC.'s revenue compounded faster (10.6% CAGR vs 6.6%).

Katapult Holdings, Inc. is a U.S.-based fintech company that provides accessible point-of-sale lease-to-purchase solutions for consumers with limited or no traditional credit history. It partners with a wide network of e-commerce platforms and brick-and-mortar retail merchants across segments including electronics, furniture and home goods to offer flexible payment plans for customers to obtain needed products.

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.

KPLT vs TMCI — Head-to-Head

Bigger by revenue
KPLT
KPLT
1.2× larger
KPLT
$73.9M
$62.5M
TMCI
Growing faster (revenue YoY)
KPLT
KPLT
+26.4% gap
KPLT
17.3%
-9.0%
TMCI
Higher net margin
KPLT
KPLT
41.9% more per $
KPLT
26.8%
-15.0%
TMCI
More free cash flow
TMCI
TMCI
$1.5M more FCF
TMCI
$-10.4M
$-12.0M
KPLT
Faster 2-yr revenue CAGR
TMCI
TMCI
Annualised
TMCI
10.6%
6.6%
KPLT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KPLT
KPLT
TMCI
TMCI
Revenue
$73.9M
$62.5M
Net Profit
$19.8M
$-9.4M
Gross Margin
15.6%
80.6%
Operating Margin
-1.4%
-9.5%
Net Margin
26.8%
-15.0%
Revenue YoY
17.3%
-9.0%
Net Profit YoY
307.3%
-1775.0%
EPS (diluted)
$3.69
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KPLT
KPLT
TMCI
TMCI
Q4 25
$73.9M
$62.5M
Q3 25
$74.0M
$50.2M
Q2 25
$71.9M
$47.4M
Q1 25
$71.9M
$52.6M
Q4 24
$63.0M
$68.7M
Q3 24
$60.3M
$45.1M
Q2 24
$58.9M
$44.5M
Q1 24
$65.1M
$51.1M
Net Profit
KPLT
KPLT
TMCI
TMCI
Q4 25
$19.8M
$-9.4M
Q3 25
$-4.9M
$-16.3M
Q2 25
$-7.8M
$-17.4M
Q1 25
$-5.7M
$-15.9M
Q4 24
$-9.6M
$-501.0K
Q3 24
$-8.9M
$-15.4M
Q2 24
$-6.9M
$-21.2M
Q1 24
$-570.0K
$-18.7M
Gross Margin
KPLT
KPLT
TMCI
TMCI
Q4 25
15.6%
80.6%
Q3 25
19.7%
79.1%
Q2 25
15.5%
79.7%
Q1 25
19.9%
79.7%
Q4 24
11.8%
80.7%
Q3 24
19.8%
80.1%
Q2 24
16.9%
80.2%
Q1 24
25.3%
80.2%
Operating Margin
KPLT
KPLT
TMCI
TMCI
Q4 25
-1.4%
-9.5%
Q3 25
3.3%
-31.2%
Q2 25
-2.0%
-35.8%
Q1 25
-0.7%
-29.6%
Q4 24
-7.7%
-0.3%
Q3 24
-7.4%
-33.6%
Q2 24
-4.5%
-48.1%
Q1 24
5.8%
-37.1%
Net Margin
KPLT
KPLT
TMCI
TMCI
Q4 25
26.8%
-15.0%
Q3 25
-6.7%
-32.4%
Q2 25
-10.9%
-36.7%
Q1 25
-7.9%
-30.3%
Q4 24
-15.2%
-0.7%
Q3 24
-14.7%
-34.1%
Q2 24
-11.7%
-47.7%
Q1 24
-0.9%
-36.5%
EPS (diluted)
KPLT
KPLT
TMCI
TMCI
Q4 25
$3.69
$-0.14
Q3 25
$-0.94
$-0.26
Q2 25
$-1.63
$-0.28
Q1 25
$-1.23
$-0.25
Q4 24
$-2.17
$-0.01
Q3 24
$-2.05
$-0.25
Q2 24
$-1.61
$-0.34
Q1 24
$-0.13
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KPLT
KPLT
TMCI
TMCI
Cash + ST InvestmentsLiquidity on hand
$22.4M
$48.4M
Total DebtLower is stronger
$55.6M
Stockholders' EquityBook value
$-38.1M
$87.3M
Total Assets
$107.9M
$190.6M
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KPLT
KPLT
TMCI
TMCI
Q4 25
$22.4M
$48.4M
Q3 25
$3.4M
$57.4M
Q2 25
$3.7M
$69.3M
Q1 25
$6.0M
$76.1M
Q4 24
$3.5M
$75.7M
Q3 24
$25.9M
$82.8M
Q2 24
$33.7M
$95.0M
Q1 24
$31.2M
$110.0M
Total Debt
KPLT
KPLT
TMCI
TMCI
Q4 25
$55.6M
Q3 25
$53.5M
Q2 25
$53.5M
Q1 25
$53.4M
Q4 24
$53.3M
Q3 24
$53.2M
Q2 24
$53.2M
Q1 24
$53.1M
Stockholders' Equity
KPLT
KPLT
TMCI
TMCI
Q4 25
$-38.1M
$87.3M
Q3 25
$-58.4M
$89.2M
Q2 25
$-54.1M
$97.6M
Q1 25
$-51.7M
$105.3M
Q4 24
$-46.8M
$112.9M
Q3 24
$-40.3M
$104.9M
Q2 24
$-32.9M
$112.1M
Q1 24
$-27.5M
$126.4M
Total Assets
KPLT
KPLT
TMCI
TMCI
Q4 25
$107.9M
$190.6M
Q3 25
$85.9M
$196.6M
Q2 25
$90.6M
$206.4M
Q1 25
$88.5M
$205.8M
Q4 24
$93.2M
$217.1M
Q3 24
$92.0M
$212.9M
Q2 24
$106.6M
$226.1M
Q1 24
$106.6M
$242.7M
Debt / Equity
KPLT
KPLT
TMCI
TMCI
Q4 25
0.64×
Q3 25
0.60×
Q2 25
0.55×
Q1 25
0.51×
Q4 24
0.47×
Q3 24
0.51×
Q2 24
0.47×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KPLT
KPLT
TMCI
TMCI
Operating Cash FlowLast quarter
$-11.9M
$-8.0M
Free Cash FlowOCF − Capex
$-12.0M
$-10.4M
FCF MarginFCF / Revenue
-16.2%
-16.7%
Capex IntensityCapex / Revenue
0.0%
3.8%
Cash ConversionOCF / Net Profit
-0.60×
TTM Free Cash FlowTrailing 4 quarters
$-29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KPLT
KPLT
TMCI
TMCI
Q4 25
$-11.9M
$-8.0M
Q3 25
$4.0M
$-9.1M
Q2 25
$-6.6M
$-3.0M
Q1 25
$3.4M
$4.2M
Q4 24
$-32.6M
$-4.2M
Q3 24
$-5.4M
$-11.8M
Q2 24
$-628.0K
$-13.9M
Q1 24
$2.0M
$-7.2M
Free Cash Flow
KPLT
KPLT
TMCI
TMCI
Q4 25
$-12.0M
$-10.4M
Q3 25
$4.0M
$-11.9M
Q2 25
$-7.8M
Q1 25
$3.4M
$655.0K
Q4 24
$-32.6M
$-7.3M
Q3 24
$-5.4M
$-14.7M
Q2 24
$-653.0K
$-15.6M
Q1 24
$-11.1M
FCF Margin
KPLT
KPLT
TMCI
TMCI
Q4 25
-16.2%
-16.7%
Q3 25
5.4%
-23.7%
Q2 25
-16.5%
Q1 25
4.7%
1.2%
Q4 24
-51.8%
-10.6%
Q3 24
-9.0%
-32.6%
Q2 24
-1.1%
-35.2%
Q1 24
-21.8%
Capex Intensity
KPLT
KPLT
TMCI
TMCI
Q4 25
0.0%
3.8%
Q3 25
0.0%
5.6%
Q2 25
0.0%
10.1%
Q1 25
0.0%
6.7%
Q4 24
0.1%
4.5%
Q3 24
0.0%
6.4%
Q2 24
0.0%
3.9%
Q1 24
0.0%
7.7%
Cash Conversion
KPLT
KPLT
TMCI
TMCI
Q4 25
-0.60×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons